Home › Funds › Atom Investors LP › IMNM
Atom Investors LP position in IMNM
IMMUNOME INC COM · Health Care
Atom Investors LP reported holding 297,489 shares of IMNM (IMMUNOME INC COM) in its Q2 2026 13F filing — a position valued at US$6.3M, representing 0.56% of its reported portfolio and ranking #14 among its reported holdings. Atom Investors LP has disclosed IMNM holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Atom Investors LP's IMNM position evolved
Atom Investors LP first disclosed a stake in IMNM in Q4 2025 at 175,767 shares (US$3.8M). The position peaked in Q1 2026 at 306,880 shares, worth US$6.7M. Across 3 filings, Atom Investors LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 297,489 shares valued at US$6.3M — a reduction of -9,391 shares quarter over quarter.. Notable position changes include a 75% increase in Q1 2026 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 175.77K | $3.78M | New |
| Q1 2026 | 306.88K | $6.71M | Add |
| Q2 2026 | 297.49K | $6.30M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMNM and 13F data
IMNM (IMMUNOME INC COM) is a Health Care company. 48 other funds we track also report a position in IMNM — the largest reported positions include Redmile Group, LLC (US$104.1M), Enavate Sciences GP, LLC (US$76.6M), SILVERARC CAPITAL MANAGEMENT, LLC (US$42.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMNM
- Redmile Group, LLC 4.91M sh · $104.08M · Q2 2026
- Enavate Sciences GP, LLC 3.61M sh · $76.58M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 2.02M sh · $42.74M · Q2 2026
- Sofinnova Investments, Inc. 1.72M sh · $36.45M · Q2 2026
- READYSTATE ASSET MANAGEMENT LP 1.61M sh · $34.03M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 732.51K sh · $15.52M · Q2 2026
- NAN FUNG TRINITY (HK) Ltd 714.55K sh · $15.14M · Q2 2026
- Parkman Healthcare Partners LLC 594.20K sh · $12.59M · Q2 2026
- ALERUS FINANCIAL NA 383.42K sh · $8.12M · Q2 2026
More on Atom Investors LP
FAQ
How long has Atom Investors LP held IMNM?
Atom Investors LP has disclosed IMNM holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Atom Investors LP's current position in IMNM?
As of Q2 2026, Atom Investors LP holds 297.49K shares of IMNM (IMMUNOME INC COM), valued at $6.30M, representing 0.56% of its reported portfolio and ranking #14.
Has Atom Investors LP been buying or selling IMNM?
In the latest 13F filing (Q2 2026), Atom Investors LP reduced its position in IMNM. The position peaked in Q1 2026 at 306.88K shares.
Which other funds hold IMNM?
Other major institutional holders of IMNM include Redmile Group, LLC, Enavate Sciences GP, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.